Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Armata Pharmaceuticals, Inc. | armp-20201231ex322242b55.htm |
| EX-32.1 - EX-32.1 - Armata Pharmaceuticals, Inc. | armp-20201231ex321f1ac6e.htm |
| EX-31.2 - EX-31.2 - Armata Pharmaceuticals, Inc. | armp-20201231ex312884e04.htm |
| EX-31.1 - EX-31.1 - Armata Pharmaceuticals, Inc. | armp-20201231ex311a990ac.htm |
| EX-23.1 - EX-23.1 - Armata Pharmaceuticals, Inc. | armp-20201231ex23138254c.htm |
| EX-4.9 - EX-4.9 - Armata Pharmaceuticals, Inc. | armp-20201231ex49554cb71.htm |
| 10-K - 10-K - Armata Pharmaceuticals, Inc. | armp-20201231x10k.htm |
Exhibit 21.1
Subsidiaries of Armata Pharmaceuticals, Inc.
The following companies are direct or indirect wholly owned subsidiaries of Armata Pharmaceuticals, Inc.:
Name |
| Jurisdiction |
C3J Therapeutics, Inc. C3 Jian, LLC | | United States United States |
Biocontrol Limited | | United Kingdom |
AmpliPhi Australia Pty Ltd | | Australia |
Special Phage Holdings Pty Ltd | | Australia |
Special Phage Services Pty Ltd | | Australia |